Before entering the lab each morning, Mariya Goncheva, PhD, puts on clean scrubs, two pairs of booties, two pairs of gloves, a gown and a full hood that covers her entire head and shoulders. She is connected by a hose to a positive pressure powered air respirator which pumps clean air into the hood....
Impact Stories | Page 5
UBC researchers are the first in the world to publish structural images of the N501Y mutation on the SARS-CoV-2 spike protein—a change believed to be partly responsible for the highly infectious nature and rapid spread of variant B.1.1.7....
As someone who has dedicated his professional life to fighting life-threatening diseases, Dr. Volker Gerdts (DVM, PhD) knows the biggest impediment to getting back to normal are those who are hesitant or refuse to be vaccinated against COVID-19....
Q&A with the experts: What can we learn from the past to help shape the future of public health in Canada?
Despite investments and advancements in health care, there are societal changes needed as we recover from COVID-19. University of Waterloo history professor Heather MacDougall sheds some light on what we can learn from the past that could help improve the health and strength of our communities....
Genome Canada launched the Canadian VirusSeq Data Portal today to track the evolving COVID-19 pandemic across Canada. McGill University researcher Guillaume Bourque, a professor in the Department of Human Genetics, along with his research team, led the development of the portal. They worked in collaboration with CanCOGeN VirusSeq and world-leading genomics scientists, including Drs. Fiona Brinkman (Simon Fraser University), William Hsiao (Simon Fraser University), Lincoln Stein (Ontario Institute for Cancer Research) and Yann Joly (McGill University)....
Between the imminent border closures and news of stay-at-home orders, for many, March 18, 2020 was defined by overwhelming uncertainty. But at the Schulich School of Medicine & Dentistry’s Pathology and Laboratory Medicine (PaLM) clinical labs, decisive action was being taken to support the COVID-19 testing needs of Southwestern Ontario....
Millions of Canadians have received the Pfizer-BioNTech COVID-19 vaccine, but what many may not realize is that a key component of the injection was developed right here at UBC....
A University of Manitoba research team is emerging as a global leader in COVID-19 anticoagulation trials thanks to their innovative, global trial studying different types of heparin, an anticoagulant (blood thinning) and anti-inflammatory drug. Early results released in January show full doses improved outcomes....
When COVID-19 lockdown measures were first introduced last year, schools and shops closed, tourist spots were deserted due to international travel restrictions, and economies slowed down as most people adjusted to life in the confines of their home....